FDA
approval
· 2017-12-19
FDA Approved: STEGLATRO — Original Application (Merck Sharp & Dohme LLC)
Summary
FDA approved STEGLATRO (ertugliflozin) in its original application for adults with type 2 diabetes mellitus to improve glycemic control, including as monotherap…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for STEGLATRO (ERTUGLIFLOZIN)